Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FX4G4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,699
Award facts
- Contract value 100% obligated
- $11,698.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 14, 2026, by the Defense Logistics Agency for Xeljanz XR 11 mg tablets in a 30-count package. The contract is structured as a firm fixed-price delivery order with no set-aside designation, valued at $11,698.65, with an ultimate completion date of January 15, 2026. The place of performance is located at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for supplying medications and medical supplies to military healthcare programs worldwide.
Amerisourcebergen Drug Corp is a child entity of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4), doing business as Amerisourcebergen. Both entities operate as critical vendors within the federal pharmaceutical supply chain and have demonstrated sustained capability to compete successfully in open market procurement. The Defense Logistics Agency, which administers medical supply chain operations for the Department of Defense, utilizes these contract vehicles to ensure military treatment facilities, the Defense Health Agency, and other federal healthcare systems maintain consistent access to essential brand-name and generic pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FX4G4?
SPE2DR26FX4G4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FX4G4 worth?
The government has obligated $11,699 on SPE2DR26FX4G4.
Is contract SPE2DR26FX4G4 an order under another contract?
Yes. SPE2DR26FX4G4 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4G4 competed?
The extent of competition for SPE2DR26FX4G4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award